[1] 吴亚丽,谢俊霞,卢楠,等.姜黄素对结肠癌细胞增殖抑制和凋亡诱导的作用研究[J].现代食品科技,2014,30(4):74-79. WU Ya-li,XIE Jun-xia,LU Nan,et al.Effects of curcumin on proliferation and apoptosis of colorectal carcinoma LoVo cells[J].Modern Food Science & Technology,2014,30(4):74-79. [2] MORIYUKI K,SEKIGUCHI F,MATSUBARA K,et al.Curcumin inhibits the proteinase-activated receptor-2-triggered prostaglandin E2 production by suppressing cyclooxygenase-2 upregulation and akt-dependent activation of nuclear factor-κB in human lung epithelial cells[J].Journal of Pharmacological Sciences,2010,114(2):225-229. [3] 旷春桃,李湘洲,薛海鹏,等.姜黄素衍生物的合成和生物活性研究[J].林产化学与工业,2014,34(5):67-72. KUANG Chun-tao,LI Xiang-zhou,XUE Hai-peng,et al.Synthesis and biological activity of curcumin derivatives[J].Chemistry and Industry of Forest Products,2014,34(5):67-72. [4] TANG Hong-mei,LU Da-xiang,PAN Rui,et al.Curcumin improves spatial memory impairment induced by human immunodeficiency virus type 1 glycoprotein 120 V3 loop peptide in rats[J].Life Sciences,2009,85(1/2):1-10. [5] SA G,DAS T.Anti cancer effects of curcumin:Cycle of life and death[J].Cell Division,2008,3(1):14. [6] 余美荣,蒋福升,丁志山.姜黄素的研究进展[J].中草药,2009,40(5):828-831. YU Mei-rong,JIANG Fu-sheng,DING Zhi-shan.Advances in studies on curcumin[J].Chinese Traditional and Herbal Drugs,2009,40(5):828-831. [7] 潘艺茗.PLA/PLGA-姜黄素纳米粒的制备与性能研究[D].广州:华南理工大学硕士学位论文,2012. PAN Yi-ming.Research on preparation and properties of curcumin-loaded PLA/PLGA nanoparticles[D].Guangzhou:Master Degress Thesis of South China University of Technology,2012. [8] KOCBEK P,BAUMGARTNER S,KRISTL J.Preparation and evaluation of nanosuspensions for enhancing the dissolution of poorly soluble drugs[J].International Journal of Pharmaceutics,2006,312(1/2):179-186. [9] MÜLLER R H,PETERS K.Nanosuspensions for the formulation of poorly soluble drugs:I.Preparation by a size-reduction technique[J].International Journal of Pharmaceutics,1998,160(2):229-237. [10] GRAU M J,KAYSER O,MÜLLER R H.Nanosuspensions of poorly soluble drugs-reproducibility of small scale production[J].International Journal of Pharmaceutics,2000,196(2):155-159. [11] 王丽丽.多西他赛脂质纳米混悬剂的研究[D].济南:山东大学硕士学位论文,2012. WANG Li-li.Preliminary studies on docetaxel-lipid-based-nanosuspensions[D].Jinan:Master Degress Thesis of Shandong University,2012. [12] 赵先英,刘毅敏,周小霞,等.度他雄胺纳米悬浮液的制备[J].西南国防医药,2013,23(12):1286-1288. ZHAO Xian-ying,LIU Yi-min,ZHOU Xiao-xia,et al.Preparation of dutasteride nanometer suspension[J].Medical Journal of National Defending Forces in Southwest China,2013,23(12):1286-1288. [13] 国家药典委员会.中华人民共和国药典(二部)[M].北京:化学工业出版社,2005. State Pharmacopeia Committee of China.Chinese Pharmacopoeia:2nd[M].Beijing:Chemical Industry Press,2005. [14] VAN EERDENBRUGH B,VAN DEN MOOTER G,AUGUSTIJNS P.Top-down production of drug nanocrystals:Nanosuspension stabilization,miniaturization and transformation into solid products[J].International Journal of Pharmaceutics,2008,364(1):64-75. [15] SINHA S,ALI M,BABOOTA S,et al.Solid dispersion as an approach for bioavailability enhancement of poorly water-soluble drug ritonavir[J].AAPS PharmSciTech,2010,11(2):518-527. [16] ZHONG Jie,SHEN Zhi-gang,YANG Yan,et al.Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment[J].International Journal of Pharmaceutics,2005,301(1/2):286-293. |